Introduction: Zinc-dependent histone deacetylases (HDAC) inhibitors represent an important class of biologically active compounds with four of them approved by the FDA. A wide range of molecules has been reported for applications in several human diseases.
Areas Covered: This review covers recent efforts in the synthesis and applications of HDAC inhibitors from 2013-2017.